Pfizer explores sale of hospital drugs unit, sources say
With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in ...
Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant.
Pfizer's head of digital devices says the industry is close to a 'revolution' in using measures from wearables in clinical ...
Pfizer has a pill it's developing called danuglipron, which is in early-stage trials but has demonstrated that it's ...
Centessa had recently conducted an interim analysis of a phase 2 study of its drug, called SerpinPC, which is designed to ...
Pfizer (PFE) is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist investor Starboard Value, looks to divest non-core assets, Reuters’ ...
Pfizer's stock underperforms the S&P 500, facing patent expirations and competition, yet offers a 6.3% forward dividend yield. Despite a positive Q3 earnings surprise, profitability remains weaker ...
But making Pfizer Inc an even more interesting and timely stock to look at, is the fact that in trading on Friday, shares of ...
Keurig Dr Pepper brings in Drew Panayiotou to accelerate digital marketing and Andrew Springate takes a new role.
Paid and presented by Pfizer. For people undergoing treatment for cancer, who are at greater risk of infection, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback